Acute cocaine induced deficits in cognitive performance in rhesus macaque monkeys treated with baclofen

Linda J. Porrino, Robert E. Hampson, Ioan Opris, Samuel A. Deadwyler

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Rationale: Acute and/or chronic exposure to cocaine can affect cognitive performance, which may influence rate of recovery during treatment. Objective: Effects of the GABA-B receptor agonist baclofen were assessed for potency to reverse the negative influence of acute, pre-session, intravenous (IV) injection of cocaine on cognitive performance in Macaca mulatta nonhuman primates. Methods: Animals were trained to perform a modified delayed match to sample (DMS) task incorporating two types of trials with varying degrees of cognitive load that had different decision requirements in order to correctly utilize information retained over the delay interval. The effects of cocaine (0.2, 0.4, and 0.6 mg/kg, IV) alone and in combination with baclofen (0.29 and 0.40 mg/kg, IV) were examined with respect to sustained performance levels. Brain metabolic activity during performance of the task was assessed using PET imaged uptake of [18 F]-fluorodeoxyglucose. Results: Acute cocaine injections produced a dose-dependent decline in DMS performance selective for trials of high cognitive load. The GABA-receptor agonist baclofen, co-administered with cocaine, reversed task performance back to nondrug (saline IV) control levels. Simultaneous assessment of PET-imaged brain metabolic activity in prefrontal cortex (PFC) showed alterations by cocaine compared to PFC metabolic activation in nondrug (saline, IV) control DMS sessions, but like performance, PFC activation was returned to control levels by baclofen (0.40 mg/kg, IV) injected with cocaine. Conclusions: The results show that baclofen, administered at a relatively high dose, reversed the cognitive deficits produced by acute cocaine intoxication that may have implications for use in chronic drug exposure.

Original languageEnglish (US)
Pages (from-to)105-114
Number of pages10
JournalPsychopharmacology
Volume225
Issue number1
DOIs
StatePublished - Jan 1 2013
Externally publishedYes

Fingerprint

Baclofen
Macaca mulatta
Cocaine
Prefrontal Cortex
Task Performance and Analysis
GABA-B Receptor Agonists
GABA Agonists
Fluorodeoxyglucose F18
Brain
Intravenous Injections
Primates
Injections

Keywords

  • Baclofen reversal of cocaine effects
  • Cocaine-impaired cognition
  • DMS cognitive task
  • Monkeys
  • PET imaging correlates

ASJC Scopus subject areas

  • Pharmacology

Cite this

Acute cocaine induced deficits in cognitive performance in rhesus macaque monkeys treated with baclofen. / Porrino, Linda J.; Hampson, Robert E.; Opris, Ioan; Deadwyler, Samuel A.

In: Psychopharmacology, Vol. 225, No. 1, 01.01.2013, p. 105-114.

Research output: Contribution to journalArticle

Porrino, Linda J. ; Hampson, Robert E. ; Opris, Ioan ; Deadwyler, Samuel A. / Acute cocaine induced deficits in cognitive performance in rhesus macaque monkeys treated with baclofen. In: Psychopharmacology. 2013 ; Vol. 225, No. 1. pp. 105-114.
@article{6d8d82b4b10042a2bc48ff49975746b0,
title = "Acute cocaine induced deficits in cognitive performance in rhesus macaque monkeys treated with baclofen",
abstract = "Rationale: Acute and/or chronic exposure to cocaine can affect cognitive performance, which may influence rate of recovery during treatment. Objective: Effects of the GABA-B receptor agonist baclofen were assessed for potency to reverse the negative influence of acute, pre-session, intravenous (IV) injection of cocaine on cognitive performance in Macaca mulatta nonhuman primates. Methods: Animals were trained to perform a modified delayed match to sample (DMS) task incorporating two types of trials with varying degrees of cognitive load that had different decision requirements in order to correctly utilize information retained over the delay interval. The effects of cocaine (0.2, 0.4, and 0.6 mg/kg, IV) alone and in combination with baclofen (0.29 and 0.40 mg/kg, IV) were examined with respect to sustained performance levels. Brain metabolic activity during performance of the task was assessed using PET imaged uptake of [18 F]-fluorodeoxyglucose. Results: Acute cocaine injections produced a dose-dependent decline in DMS performance selective for trials of high cognitive load. The GABA-receptor agonist baclofen, co-administered with cocaine, reversed task performance back to nondrug (saline IV) control levels. Simultaneous assessment of PET-imaged brain metabolic activity in prefrontal cortex (PFC) showed alterations by cocaine compared to PFC metabolic activation in nondrug (saline, IV) control DMS sessions, but like performance, PFC activation was returned to control levels by baclofen (0.40 mg/kg, IV) injected with cocaine. Conclusions: The results show that baclofen, administered at a relatively high dose, reversed the cognitive deficits produced by acute cocaine intoxication that may have implications for use in chronic drug exposure.",
keywords = "Baclofen reversal of cocaine effects, Cocaine-impaired cognition, DMS cognitive task, Monkeys, PET imaging correlates",
author = "Porrino, {Linda J.} and Hampson, {Robert E.} and Ioan Opris and Deadwyler, {Samuel A.}",
year = "2013",
month = "1",
day = "1",
doi = "10.1007/s00213-012-2798-6",
language = "English (US)",
volume = "225",
pages = "105--114",
journal = "Psychopharmacology",
issn = "0033-3158",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Acute cocaine induced deficits in cognitive performance in rhesus macaque monkeys treated with baclofen

AU - Porrino, Linda J.

AU - Hampson, Robert E.

AU - Opris, Ioan

AU - Deadwyler, Samuel A.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Rationale: Acute and/or chronic exposure to cocaine can affect cognitive performance, which may influence rate of recovery during treatment. Objective: Effects of the GABA-B receptor agonist baclofen were assessed for potency to reverse the negative influence of acute, pre-session, intravenous (IV) injection of cocaine on cognitive performance in Macaca mulatta nonhuman primates. Methods: Animals were trained to perform a modified delayed match to sample (DMS) task incorporating two types of trials with varying degrees of cognitive load that had different decision requirements in order to correctly utilize information retained over the delay interval. The effects of cocaine (0.2, 0.4, and 0.6 mg/kg, IV) alone and in combination with baclofen (0.29 and 0.40 mg/kg, IV) were examined with respect to sustained performance levels. Brain metabolic activity during performance of the task was assessed using PET imaged uptake of [18 F]-fluorodeoxyglucose. Results: Acute cocaine injections produced a dose-dependent decline in DMS performance selective for trials of high cognitive load. The GABA-receptor agonist baclofen, co-administered with cocaine, reversed task performance back to nondrug (saline IV) control levels. Simultaneous assessment of PET-imaged brain metabolic activity in prefrontal cortex (PFC) showed alterations by cocaine compared to PFC metabolic activation in nondrug (saline, IV) control DMS sessions, but like performance, PFC activation was returned to control levels by baclofen (0.40 mg/kg, IV) injected with cocaine. Conclusions: The results show that baclofen, administered at a relatively high dose, reversed the cognitive deficits produced by acute cocaine intoxication that may have implications for use in chronic drug exposure.

AB - Rationale: Acute and/or chronic exposure to cocaine can affect cognitive performance, which may influence rate of recovery during treatment. Objective: Effects of the GABA-B receptor agonist baclofen were assessed for potency to reverse the negative influence of acute, pre-session, intravenous (IV) injection of cocaine on cognitive performance in Macaca mulatta nonhuman primates. Methods: Animals were trained to perform a modified delayed match to sample (DMS) task incorporating two types of trials with varying degrees of cognitive load that had different decision requirements in order to correctly utilize information retained over the delay interval. The effects of cocaine (0.2, 0.4, and 0.6 mg/kg, IV) alone and in combination with baclofen (0.29 and 0.40 mg/kg, IV) were examined with respect to sustained performance levels. Brain metabolic activity during performance of the task was assessed using PET imaged uptake of [18 F]-fluorodeoxyglucose. Results: Acute cocaine injections produced a dose-dependent decline in DMS performance selective for trials of high cognitive load. The GABA-receptor agonist baclofen, co-administered with cocaine, reversed task performance back to nondrug (saline IV) control levels. Simultaneous assessment of PET-imaged brain metabolic activity in prefrontal cortex (PFC) showed alterations by cocaine compared to PFC metabolic activation in nondrug (saline, IV) control DMS sessions, but like performance, PFC activation was returned to control levels by baclofen (0.40 mg/kg, IV) injected with cocaine. Conclusions: The results show that baclofen, administered at a relatively high dose, reversed the cognitive deficits produced by acute cocaine intoxication that may have implications for use in chronic drug exposure.

KW - Baclofen reversal of cocaine effects

KW - Cocaine-impaired cognition

KW - DMS cognitive task

KW - Monkeys

KW - PET imaging correlates

UR - http://www.scopus.com/inward/record.url?scp=84872309418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872309418&partnerID=8YFLogxK

U2 - 10.1007/s00213-012-2798-6

DO - 10.1007/s00213-012-2798-6

M3 - Article

C2 - 22836369

AN - SCOPUS:84872309418

VL - 225

SP - 105

EP - 114

JO - Psychopharmacology

JF - Psychopharmacology

SN - 0033-3158

IS - 1

ER -